Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MEDIFAST INCMED · Entity 6587 | Director | July 17, 2020 | July 22, 2020 |
| TRANSCAT INCTRNS · Entity 1920 | Director | May 26, 2022 | May 31, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MEDIFAST INC
Report date July 17, 2020 · Filed July 22, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,199 |
Reported balance
After 2020-07-17 transaction · row 1
1 source rowRow 1 · 2020-07-17 · Gift · Disposed 311 · Balance 18,199 |
TRANSCAT INC
Report date May 26, 2022 · Filed May 31, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.50 par valueSEC Table I · non-derivative | Direct | 45,095 |
Reported balance
After 2022-05-26 transaction · row 1
1 source rowRow 1 · 2022-05-26 · Sale · Disposed 20,000 · Balance 45,095 F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.11 to $64.03, inclusive. Mr. Sassano undertakes to provide Transcat, Inc., any security holder of Transcat, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 756 |
Reported balance
Holding disclosure · report date 2022-05-26 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 756 F2: These restricted stock units, which convert into common stock on a one-for-one basis, vest on September 8, 2022, except as otherwise provided in the award agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.11 to $64.03, inclusive. Mr. Sassano undertakes to provide Transcat, Inc., any security holder of Transcat, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: These restricted stock units, which convert into common stock on a one-for-one basis, vest on September 8, 2022, except as otherwise provided in the award agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2022 Filed May 31, 2022 20:17 UTC | TRANSCAT INC TRNS · Entity 1920 | SaleCommon Stock, $.50 par value | 20,000 | $63.14 | $1,262,800.00 |
DisclosureSEC source: 0001062993-22-013861 · form4.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,095 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.11 to $64.03, inclusive. Mr. Sassano undertakes to provide Transcat, Inc., any security holder of Transcat, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 09, 2021 Filed Sep 9, 2021 20:26 UTC | TRANSCAT INC TRNS · Entity 1920 | Exercise / conversionRestricted Stock Units · Derivative | 1,753 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000891839-21-000290 · edgar.xml · derivative · entry 3 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.50 par value · 1,753 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: These restricted stock units vested on September 9, 2021. F3 · derivative.expiration_date: These restricted stock units vested on September 9, 2021. Read SEC document |
| September 09, 2021 Filed Sep 9, 2021 20:26 UTC | TRANSCAT INC TRNS · Entity 1920 | Exercise / conversionCommon Stock, $.50 par value | 1,753 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-21-000290 · edgar.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 20:26 UTC | TRANSCAT INC TRNS · Entity 1920 | GrantRestricted Stock Units · Derivative | 756 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000891839-21-000290 · edgar.xml · derivative · entry 2 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756 Underlying: Common Stock, $.50 par value · 756 shares Expires not disclosed F2 · derivative.exercise_price: These restricted stock units, which convert into common stock on a one-for-one basis, were granted in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award agreement, vest on September 8, 2022. F2 · derivative.exercise_date: These restricted stock units, which convert into common stock on a one-for-one basis, were granted in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award agreement, vest on September 8, 2022. F2 · derivative.expiration_date: These restricted stock units, which convert into common stock on a one-for-one basis, were granted in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award agreement, vest on September 8, 2022. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 20:22 UTC | TRANSCAT INC TRNS · Entity 1920 | Exercise / conversionRestricted Stock Units · Derivative | 2,196 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000891839-20-000289 · edgar.xml · derivative · entry 2 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.50 par value · 2,196 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: These restricted stock units vested on September 11, 2020. F2 · derivative.expiration_date: These restricted stock units vested on September 11, 2020. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 20:22 UTC | TRANSCAT INC TRNS · Entity 1920 | Exercise / conversionCommon Stock, $.50 par value | 2,196 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-20-000289 · edgar.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 20:10 UTC | TRANSCAT INC TRNS · Entity 1920 | GrantRestricted Stock Units · Derivative | 1,753 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000891839-20-000275 · edgar.xml · derivative · entry 2 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,753 Underlying: Common Stock, $.50 par value · 1,753 shares Expires not disclosed F1 · derivative.exercise_price: These restricted stock units, which convert into common stock on a one-for-one basis, were granted under the Transcat, Inc. 2003 Incentive Plan, as amended, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vest on September 9, 2021. F1 · derivative.exercise_date: These restricted stock units, which convert into common stock on a one-for-one basis, were granted under the Transcat, Inc. 2003 Incentive Plan, as amended, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vest on September 9, 2021. F1 · derivative.expiration_date: These restricted stock units, which convert into common stock on a one-for-one basis, were granted under the Transcat, Inc. 2003 Incentive Plan, as amended, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vest on September 9, 2021. Read SEC document |
| July 17, 2020 Filed Jul 22, 2020 21:32 UTC | MEDIFAST INC MED · Entity 6587 | GiftCommon Stock | 311 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-085708 · tm2025382-3_4.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,199 Read SEC document |
| June 16, 2020 Filed Jun 19, 2020 00:40 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-074831 · tm2022977d5_4.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,510 F1 · shares: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2021. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 21:34 UTC | TRANSCAT INC TRNS · Entity 1920 | SaleCommon Stock, $.50 par value | 6,600 | $30.18 | $199,188.00 |
DisclosureSEC source: 0000891839-20-000055 · edgar.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,884 Read SEC document |
| September 11, 2019 Filed Sep 13, 2019 20:27 UTC | TRANSCAT INC TRNS · Entity 1920 | GrantRestricted Stock Units · Derivative | 2,196 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000891839-19-000173 · edgar.xml · derivative · entry 2 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,196 Underlying: Common Stock, $.50 par value · 2,196 shares Expires not disclosed F1 · derivative.exercise_price: These restricted stock units, which convert into common stock on a one-for-one basis, were granted under the Transcat, Inc. 2003 Incentive Plan, as amended, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vest on September 11, 2020. F1 · derivative.exercise_date: These restricted stock units, which convert into common stock on a one-for-one basis, were granted under the Transcat, Inc. 2003 Incentive Plan, as amended, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vest on September 11, 2020. F1 · derivative.expiration_date: These restricted stock units, which convert into common stock on a one-for-one basis, were granted under the Transcat, Inc. 2003 Incentive Plan, as amended, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vest on September 11, 2020. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 20:32 UTC | TRANSCAT INC TRNS · Entity 1920 | GiftCommon Stock, $.50 par value | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-19-000114 · edgar.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,484 Read SEC document |
| June 03, 2019 Filed Jun 6, 2019 23:14 UTC | MEDIFAST INC MED · Entity 6587 | GiftCommon Stock | 365 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-030143 · tv523260_4.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,427 Read SEC document |
| May 28, 2019 Filed May 29, 2019 20:33 UTC | TRANSCAT INC TRNS · Entity 1920 | SaleCommon Stock, $.50 par value | 5,000 | $24.85 | $124,250.00 |
DisclosureSEC source: 0000891839-19-000091 · edgar.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,484 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.70 to $25.04 per share, inclusive. Mr. Sassano undertakes to provide to Transcat, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| May 22, 2019 Filed May 23, 2019 20:34 UTC | TRANSCAT INC TRNS · Entity 1920 | GrantCommon Stock, $.50 par value | 1,305 | $22.98 | $29,988.90 |
DisclosureSEC source: 0000891839-19-000079 · edgar.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,484 Read SEC document |
| May 08, 2019 Filed May 9, 2019 21:35 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 850 | $143.94 | $122,349.00 |
DisclosureSEC source: 0001144204-19-024980 · tv521196_4.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,792 Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 18:37 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionStock Option (Right to Buy) · Derivative | 486 | $0.00 Strike: $26.52 | $0.00 |
DisclosureSEC source: 0001562180-19-002011 · primarydocument.xml · derivative · entry 4 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 486 shares Expires 2024-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options vested in three equal annual installments beginning on February 5, 2015. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 18:37 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $27.68 | $0.00 |
DisclosureSEC source: 0001562180-19-002011 · primarydocument.xml · derivative · entry 3 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2026-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options vested in three equal annual installments beginning on February 4, 2017. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 18:37 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionCommon Stock | 486 | $26.52 | $12,888.72 |
DisclosureSEC source: 0001562180-19-002011 · primarydocument.xml · nonDerivative · entry 2 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 18:37 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionCommon Stock | 5,000 | $27.68 | $138,400.00 |
DisclosureSEC source: 0001562180-19-002011 · primarydocument.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 00:06 UTC | MEDIFAST INC MED · Entity 6587 | SaleCommon Stock | 5,000 | $135.47 | $677,350.00 |
DisclosureSEC source: 0001144204-19-013788 · tv516197_4.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,156 Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:00 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-19-010328 · tv514785_4.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,156 F1 · shares: Represents an annual grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in full on June 30, 2020. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 01, 2018 Filed Apr 30, 2021 20:33 UTC | TRANSCAT INC TRNS · Entity 1920 | GiftCommon Stock, $.50 par value | 1,738 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-21-000121 · edgar.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,342 F1 · balance_after: This filing reflects the holdings of the reporting person as of the date of this filing. Read SEC document |
| October 01, 2018 Filed Oct 2, 2018 20:40 UTC | TRANSCAT INC TRNS · Entity 1920 | GiftCommon Stock, $.50 par value | 5,812 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-18-000095 · edgar.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,179 Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 22:22 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionStock Option · Derivative | 5,000 | $0.00 Strike: $31.55 | $0.00 |
DisclosureSEC source: 0001144204-18-041746 · tv500053_4.xml · derivative · entry 2 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2025-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options vested in three equal installments, beginning on 2/17/2016 Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 22:22 UTC | MEDIFAST INC MED · Entity 6587 | Exercise / conversionCommon Stock | 5,000 | $31.55 | $157,750.00 |
DisclosureSEC source: 0001144204-18-041746 · tv500053_4.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2018 Filed Jul 3, 2018 20:22 UTC | MEDIFAST INC MED · Entity 6587 | GiftCommon Stock | 372 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-037237 · tv497969_4.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,448 Read SEC document |
| May 23, 2018 Filed May 24, 2018 21:01 UTC | TRANSCAT INC TRNS · Entity 1920 | GrantCommon Stock, $.50 par value | 1,916 | $15.65 | $29,985.40 |
DisclosureSEC source: 0000891839-18-000044 · edgar.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,991 Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 23:22 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 1,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-007045 · tv485455_form4.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,820 F1 · shares: This annual restricted stock grant, which was issued to the reporting person under the 2012 Share Incentive Plan, will vest in full on June 30, 2019. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 23:06 UTC | TRANSCAT INC TRNS · Entity 1920 | SaleCommon Stock, $.50 par value | 7,500 | $13.02 | $97,650.00 |
DisclosureSEC source: 0000891839-17-000107 · edgar.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,075 Read SEC document |
| May 15, 2017 Filed May 17, 2017 21:59 UTC | TRANSCAT INC TRNS · Entity 1920 | Disposition to issuerStock Option (Right to Buy) · Derivative | 10,032 | Not disclosed Strike: $7.72 | Not disclosed |
DisclosureSEC source: 0000891839-17-000068 · edgar.xml · derivative · entry 2 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.50 par value · 10,032 shares Expires 2017-07-30 F1 · derivative.exercise_price: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on May 15, 2017 ($12.28) less the exercise price ($7.72). F1 · kind: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on May 15, 2017 ($12.28) less the exercise price ($7.72). F1 · shares: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on May 15, 2017 ($12.28) less the exercise price ($7.72). F1 · price: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on May 15, 2017 ($12.28) less the exercise price ($7.72). F1 · derivative.underlying_shares: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on May 15, 2017 ($12.28) less the exercise price ($7.72). Read SEC document |
| April 15, 2017 Filed Apr 18, 2017 20:26 UTC | TRANSCAT INC TRNS · Entity 1920 | Disposition to issuerStock Option (Right to Buy) · Derivative | 10,032 | Not disclosed Strike: $7.72 | Not disclosed |
DisclosureSEC source: 0000891839-17-000050 · edgar.xml · derivative · entry 2 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,032 Underlying: Common Stock, $.50 par value · 10,032 shares Expires 2017-07-30 F1 · derivative.exercise_price: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on April 13, 2017 ($12.10) less the exercise price ($7.72). F1 · kind: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on April 13, 2017 ($12.10) less the exercise price ($7.72). F1 · shares: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on April 13, 2017 ($12.10) less the exercise price ($7.72). F1 · price: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on April 13, 2017 ($12.10) less the exercise price ($7.72). F1 · derivative.underlying_shares: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on April 13, 2017 ($12.10) less the exercise price ($7.72). Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 20:32 UTC | TRANSCAT INC TRNS · Entity 1920 | Disposition to issuerStock Option (Right to Buy) · Derivative | 10,032 | Not disclosed Strike: $7.72 | Not disclosed |
DisclosureSEC source: 0000891839-17-000047 · edgar.xml · derivative · entry 2 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,064 Underlying: Common Stock, $.50 par value · 10,032 shares Expires 2017-07-30 F1 · derivative.exercise_price: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on March 14, 2017 ($12.50) less the exercise price ($7.72). F1 · kind: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on March 14, 2017 ($12.50) less the exercise price ($7.72). F1 · shares: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on March 14, 2017 ($12.50) less the exercise price ($7.72). F1 · price: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on March 14, 2017 ($12.50) less the exercise price ($7.72). F1 · derivative.underlying_shares: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on March 14, 2017 ($12.50) less the exercise price ($7.72). Read SEC document |
| February 16, 2017 Filed Feb 22, 2017 00:55 UTC | MEDIFAST INC MED · Entity 6587 | GrantCommon Stock | 2,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-010261 · v460097_4.xml · nonDerivative · entry 1 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,540 F1 · shares: This annual restricted stock grant, which was issued to the reporting person under the 2012 Share Incentive Plan, will vest in full on June 30, 2018. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 21:24 UTC | TRANSCAT INC TRNS · Entity 1920 | Disposition to issuerStock Option (Right to Buy) · Derivative | 10,032 | Not disclosed Strike: $7.72 | Not disclosed |
DisclosureSEC source: 0000891839-17-000038 · edgar.xml · derivative · entry 2 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,096 Underlying: Common Stock, $.50 par value · 10,032 shares Expires 2017-07-30 F1 · derivative.exercise_price: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on February 14, 2017 ($11.40) less the exercise price ($7.72). F1 · kind: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on February 14, 2017 ($11.40) less the exercise price ($7.72). F1 · shares: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on February 14, 2017 ($11.40) less the exercise price ($7.72). F1 · price: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on February 14, 2017 ($11.40) less the exercise price ($7.72). F1 · derivative.underlying_shares: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on February 14, 2017 ($11.40) less the exercise price ($7.72). Read SEC document |
| January 15, 2017 Filed Jan 18, 2017 21:39 UTC | TRANSCAT INC TRNS · Entity 1920 | Disposition to issuerStock Option (Right to Buy) · Derivative | 10,032 | Not disclosed Strike: $7.72 | Not disclosed |
DisclosureSEC source: 0000891839-17-000025 · edgar.xml · derivative · entry 3 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,128 Underlying: Common Stock, $.50 par value · 10,032 shares Expires 2017-07-30 F2 · derivative.exercise_price: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on January 13, 2017 ($10.55) less the exercise price ($7.72). F2 · kind: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on January 13, 2017 ($10.55) less the exercise price ($7.72). F2 · shares: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on January 13, 2017 ($10.55) less the exercise price ($7.72). F2 · price: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on January 13, 2017 ($10.55) less the exercise price ($7.72). F2 · derivative.underlying_shares: This option was redeemed by the Company in a transaction exempt under Rule 16b-3(e) pursuant to a letter agreement dated January 10, 2017 between the Company and Mr. Sassano providing for recurring monthly redemptions. Pursuant to the letter agreement, the redemption price was calculated based on the closing price of the Company's common stock on January 13, 2017 ($10.55) less the exercise price ($7.72). Read SEC document |
| November 07, 2016 Filed Jan 18, 2017 21:39 UTC | TRANSCAT INC TRNS · Entity 1920 | Disposition to issuerStock Option (Right to Buy) · Derivative | 10,000 | Not disclosed Strike: $7.72 | Not disclosed |
DisclosureSEC source: 0000891839-17-000025 · edgar.xml · derivative · entry 2 SASSANO CARL E · CIK 0001225020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,160 Underlying: Common Stock, $.50 par value · 10,000 shares Expires 2017-07-30 F1 · derivative.exercise_price: This option was redeemed by the Company under the terms of the Transcat, Inc. 2003 Incentive Plan, as Amended and Restated, in a transaction exempt under Rule 16b-3(e). The redemption price was calculated based on the closing price of the Company's common stock on November 2, 2016 ($10.15) less the exercise price ($7.72). F1 · kind: This option was redeemed by the Company under the terms of the Transcat, Inc. 2003 Incentive Plan, as Amended and Restated, in a transaction exempt under Rule 16b-3(e). The redemption price was calculated based on the closing price of the Company's common stock on November 2, 2016 ($10.15) less the exercise price ($7.72). F1 · shares: This option was redeemed by the Company under the terms of the Transcat, Inc. 2003 Incentive Plan, as Amended and Restated, in a transaction exempt under Rule 16b-3(e). The redemption price was calculated based on the closing price of the Company's common stock on November 2, 2016 ($10.15) less the exercise price ($7.72). F1 · price: This option was redeemed by the Company under the terms of the Transcat, Inc. 2003 Incentive Plan, as Amended and Restated, in a transaction exempt under Rule 16b-3(e). The redemption price was calculated based on the closing price of the Company's common stock on November 2, 2016 ($10.15) less the exercise price ($7.72). F1 · derivative.underlying_shares: This option was redeemed by the Company under the terms of the Transcat, Inc. 2003 Incentive Plan, as Amended and Restated, in a transaction exempt under Rule 16b-3(e). The redemption price was calculated based on the closing price of the Company's common stock on November 2, 2016 ($10.15) less the exercise price ($7.72). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.